Mutations in the runt homology domain of CBFα2 in myeloid malignancies with acquired trisomy 21
- 1 July 2002
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 136 (2) , 151-152
- https://doi.org/10.1016/s0165-4608(02)00525-3
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- AML1–ETO downregulates the granulocytic differentiation factor C/EBPα in t(8;21) myeloid leukemiaNature Medicine, 2001
- Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-α (C/EBPα), in acute myeloid leukemiaNature Genetics, 2001
- Clinical importance of cytogenetics in acute myeloid leukaemiaBest Practice & Research Clinical Haematology, 2001
- Mutations of the AML1 gene in myelodysplastic syndrome and their functional implications in leukemogenesisBlood, 2000
- High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2αB gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21Blood, 2000
- Biallelic and Heterozygous Point Mutations in the Runt Domain of theAML1/PEBP2B Gene Associated With Myeloblastic LeukemiasBlood, 1999